Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
CD22 CAR-T
Locations
2
China
Hebei yanda Ludaopei Hospital
Heibei, Sanhe, China
BeiJing Ludaopei Hospital
Beijing, Yizhuang, China
Start Date
September 1, 2020
Primary Completion Date
September 1, 2022
Completion Date
December 1, 2022
Last Updated
September 14, 2020
NCT05442515
NCT04276870
NCT04781634
NCT06678282
NCT05397496
NCT02315612
Lead Sponsor
Hebei Senlang Biotechnology Inc., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions